Pathogen Strain Variants
Pathogen Strain Variants - Related Videos
02:25
Culturing and Isolating Capsule-Forming Pathogenic Bacterial Strains
0 Views •
2025
Source: Feltwell, T., et.al. Separating Bacteria by Capsule Amount Using a Discontinuous Density Gradient. J. Vis. Exp. (2019)This video demonstrates the preparation and characterization of bacterial strains with varying capsule production. Pathogenic strains carrying different mutations in capsule-related genes are cultured, grown in liquid media, and subjected to centrifugation to distinguish capsule phenotypes based on pellet density. Buffer treatment is used to wash and stabilize the cells...
02:12
Muscle Necrosis Assay in C. elegans Induced by a Pathogenic Aeromonas Strain
0 Views •
2026
Source: Chen, Y. et. al., Evaluating Virulence and Pathogenesis of Aeromonas Infection in a Caenorhabditis elegans Model. J. Vis. Exp. (2018)This video demonstrates a muscle necrosis assay in C. elegans (Caenorhabditis elegans) using pathogenic Aeromonas strains. By feeding green fluorescent protein (GFP)-expressing worms on Aeromonas-seeded plates, the assay models bacterial infection and reveals tissue damage through fluorescence imaging. The progressive loss of muscle structure and GFP...
03:20
Generation of Influenza Virus Escape Variants against Neutralizing Antibodies
0 Views •
2025
This video demonstrates a technique for generating escape variants of neutralizing influenza virus monoclonal antibodies. Antibody-neutralized virus suspension is injected into embryonated chicken eggs to propagate escape variants selectively. This results in a virus population predominantly of escape variants, confirmed via a Hemagglutination assay.
10:39
Single Cell Measurements of Vacuolar Rupture Caused by Intracellular Pathogens
0 Views •
Cited by 22 •
2013
We describe a method for tracking the endomembrane rupture elicited by the intracellular bacteria Shigella flexneri and Mycobacterium tuberculosis upon host cell invasion. Our assay makes use of CCF4, a host cytoplasmic FRET probe in live or fixed cells. This reporter is degraded by an enzyme activity present on the bacterial surface.
07:55
Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies
0 Views •
Cited by 10 •
2017
We describe a method by which we identify critical residues required for the binding of human or murine monoclonal antibodies that target the viral hemagglutinin of influenza A viruses. The protocol can be adapted to other virus surface glycoproteins and their corresponding neutralizing antibodies.
FAQs
Mutation can introduce genetic changes, while genetic recombination can produce new combinations of existing genetic material. Natural selection then favors traits that improve a pathogen’s success under particular transmission conditions, host defenses, or environmental pressures. Together, these mechanisms can shift replication efficiency, surface antigens, and other characteristics that influence infection and spread.
Surface antigens are features that the immune system can recognize, so changes in them may alter how effectively existing immune responses identify a pathogen. Comparing antigenic differences among strains helps explain why immunity may vary between individuals or pathogens. This information is especially relevant when evaluating how infection or prior immune exposure relates to recognition.
Differences in transmissibility, disease severity, immune recognition, and response to treatment can change the consequences of infection. A strain with altered replication efficiency may behave differently during transmission or infection, while changes affecting treatment response may complicate control. Examining these traits together provides a broader view of how pathogen variation influences disease outcomes.
Researchers compare genetic characteristics with infection-related traits, including surface antigens, replication efficiency, immune recognition, disease severity, transmissibility, and treatment response. Molecular surveillance supports this comparison by tracking relevant changes across strains. The resulting information helps connect genetic variation with differences in host interaction and provides evidence for understanding pathogen adaptation.
Variant comparisons can identify changes that affect immune recognition or response to treatment, providing context for vaccine and therapeutic development. Understanding which strain characteristics differ helps researchers assess whether existing approaches remain relevant across pathogen forms. This work also clarifies how adaptation may influence the effectiveness of interventions during changing infection patterns.
Molecular surveillance helps identify and track genetically distinct pathogen forms as they arise and spread. Linking genetic changes with traits such as transmissibility, disease severity, immune recognition, or treatment response can improve interpretation of evolving outbreaks. These insights strengthen infectious disease control by supporting more informed assessment of pathogen adaptation and response strategies.